Entering text into the input field will update the search result below

(DOX, PWRM, BKH, FIO, NHPR) Stock in Review by Stock-PR.com

Jun. 30, 2011 9:36 AM ET
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Stock-PR Reporting

stockpr_logo-site

FREE Daily Stock Alerts From Stock-PR.com

chartstockalert

Amdocs Ltd. (NYSE:DOX) announced that Telenor Serbia with help of local partner, S&T Serbia, has deployed Amdocs OSS (operational support systems) as the inventory and planning system to support the first phase of its OSS transformation project. Telenor Serbia's OSS transformation project is designed to enable the mobile operator to deploy and manage an all-IP next-generation network (NGN) that will offer new services to its 3.059 million subscribers. The announcement was made in conjunction with Amdocs' Asia Pacific InTouch Business Forum, the company's annual customer and partner event taking place in Singapore this week.

Amdocs Limited, through its subsidiaries, provides software and services to the communications, media, and entertainment industry service providers worldwide. The company’s software systems support revenue management, customer management, service and resource management, and service delivery.

*******************

power3 Power3 Medical Products, Inc. (PWRM)

Power3 Medical
applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

The NuroPro Blood Test is Power3's medical diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer's disease, ALS (Lou Gehrig's disease), and Parkinson's disease. Early detection of these diseases will allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease).

Some of the symptoms of Alzheimer's disease are:

" Have trouble making decisions.
" Be confused about what time and day it is.
" Get lost in places he or she knows well.
" Have trouble learning and remembering new information.
" Have trouble finding the right words to say what he or she wants to say.

Please visit Power3 Medical Products, Inc website http://www.power3medical.com.

*******************

Black Hills Corp. (NYSE:BKH) announced the closing of a $150 million, one-year, unsecured, single-draw, term loan with CoBank, Scotia Bank and U.S. Bank. The cost of borrowing under the loan is based on a spread of 125 basis points over LIBOR. "This loan captures the benefits of low short-term interest rates that currently exist in the market place and reduces our overall cost of short-term borrowing," said Tony Cleberg, executive vice president and chief financial officer of Black Hills Corp.

Black Hills Corp. a diversified energy company with a tradition of exemplary service and a vision to be the energy partner of choice - is based in Rapid City, S.D., with corporate offices in Denver and Papillion, Neb.More information is available at
www.blackhillscorp.com.

*******************

Fusion-io Inc. (NYSE:FIO) announced that its technology has been utilized to realize significant performance improvements in MySQL database queries for bioinformatics research. The Protein Data Bank (PDB) research is being conducted at the University of California, San Diego, in collaboration with the San Diego Supercomputer Center (SDSC). Researchers at SDSC noted that replacing hard drive disks (HDDs) with Fusion-io technology in their database infrastructure reduced query times from 30 minutes to three minutes.

Fusion-io, Inc. focuses on the development, marketing, and sale of storage memory platforms for data decentralization. The company’s platform enhances the processing capabilities within a datacenter by relocating process-critical or active data from centralized storage to the server where it is being processed.

*********************

http://pennyomega.com/img/nhpr.jpg National Health Partners, Inc. (NHPR)

National Health Partners, Inc. is a national healthcare savings organization that provides discount healthcare membership programs to uninsured and underinsured people through a national healthcare savings network called "CARExpress." CARExpress is one of the largest networks of hospitals, doctors, dentists, pharmacists and other healthcare providers in the country and is comprised of over 1,000,000 medical professionals that belong to such PPOs as CareMark and Aetna. National Health Partners, Inc primary target customer group is the 47 million Americans who have no health insurance of any kind. The company's secondary target customer group includes the millions of Americans who lack complete health insurance coverage.

In the U.S., the private sector bears a large part of the burden of rapidly rising health care costs because about three-fifths of all Americans have employer-sponsored health insurance. The popularity of employer provided insurance in the US partly stems from the fact that employer contributions to health insurance premiums are exempt from income and payroll taxes. Higher health insurance premiums may erode profits. In fact, some employers now view increasing premiums for health insurance as important to their profitability as rising energy costs and broader economic trends.

National Health Partners, Inc., a leading provider of discount healthcare membership programs, announced the recent signing of two new significant marketing agreements. These two clients provide very different opportunities and continue to expand the reach of CARExpress into new marketplaces.

By launching their own unique internet marketing program, the first group should be able to provide a widespread push into the on-line market to produce an excellent volume of new CARExpress sales into the pipeline. In addition, the second group offers a reach into the wholesale marketplace where CARExpress will be wrapped into other programs to enhance the value of the overall package to the consumer. They would consider this non-traditional business and a great opportunity to expand their reach as well as recognition of the CARExpress program nationwide.

The company plans to announce the rollout of these new marketing campaigns as well as several others over the next few weeks.

For more information about National Health Partners, Inc. visit its website at www.nationalhealthpartners.com

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB). Crown Equity Holdings Inc. (OTCPK:CRWE) has received 3,000,000 shares of (144) restricted common stock from the company and 3,000,000 shares of free trading shares from a third party (PIERRE BESUCHET) for six months of advertisement services for National Health Partners Inc. (NHPR.OB).

Sign Up For Free Stock Alerts At http://stock-pr.com/signup

http://stock-pr.com/img/stock-pr_buscard.jpg

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You